作为糖科学和糖医学应用的基础的小莱克连接物
Paul V Murphy1,2,3, Ashis Dhara1,2, Liam S Fitzgerald1,2,3
1School of Biological and Chemical Sciences, Galway, H91TK33, Ireland. paul.v.murphy@universityofgalway.ie.
Chemical Society reviews
|August 20, 2024
概括
莱克与甘氨酸结合,引发生物事件. 了解这些相互作用激发了针对性疗法和诊断的新型甘氨基仿制配体.
科学领域:
- 碳水化合物化学 碳水化合物化学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 乳清素是蛋白质,可以结合特定的碳水化合物结构 (糖).
- 甘氨酸与莱克的相互作用对许多生物过程至关重要,包括细胞对细胞的识别和免疫反应.
- 这些相互作用的失调与各种疾病有关.
研究的目的:
- 为了提供一个介绍性概述的莱克-配体相互作用.
- 要突出如何理解这些相互作用驱动联结体设计的创新.
- 展示治疗和诊断领域的应用.
主要方法:
- 对莱克-甘氨酸识别的基本原则的审查.
- 探索设计糖仿性联体的策略.
- 讨论多价位连接体方法 (激动剂/对抗剂).
- 针对向治疗 (疫苗,siRNA,LYTACs) 和诊断的配体的案例研究.
主要成果:
- 莱克对甘氨酸的识别是生物调节的多功能平台.
- 了解自然连接体结构使得合成连接体的合理设计成为可能.
- 工程联体可以实现高特异性和亲和力,用于治疗和诊断目的.
结论:
- 莱克 - 连接体相互作用为开发新型甘油仿真工具提供了丰富的灵感来源.
- 这些工具在推进精准医学和诊断方面具有重大潜力.
- 对糖甘识别的进一步研究将继续释放创新的应用.
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Protein Glycosylation
6.8K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.8K
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Glycocalyx and its Functions
3.9K
The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
3.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Glucagon-like Receptor Agonists
308
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
308


